Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $159.6M |
| Sales growthchange from the year before | +33.7% |
| Operating marginshare of sales left after running the business | 44.5% |
| Net marginshare of sales kept as profit | 23.4% |
| Return on equityprofit vs. shareholders' accounting value | n/m |
| Debt / equitydebt vs. shareholders' accounting value | n/m |
| Change in share countnegative = the company is buying back its shares | +11.9% |
2 insiders sold $116.3M on the open market.
| Ftv Vii, L.P.; FTV NE-Aggregator, LLC; Growth VII-Centre, L.P.; FTV Management VII, L.P.10% owner | SoldJul 29 | 1,867,840 shat $33.22 · $62.0M |
| BSIV Hold 101, LP; BSIV Hold 101 GP, LLC; Bregal Sagemount IV General Partner Jersey Ltd; Bregal Sagemount Management LP; Yoon Gene10% owner | SoldJul 29 | 1,632,160 shat $33.22 · $54.2M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy